Press

Arrive Health has completed an analysis of 78 million prescription transactions and found that 46.78% of the time, patients have an option that would cost $0.

Arrive Health has acquired a suite of innovative patient engagement and automation technologies developed by UPMC Enterprises and the UPMC Pharmacy Network.

Increasing access to cost information is a dramatic improvement for UCHealth doctors and patients.

By confirming patient coverage and offering resources such as generic alternatives, pharmacists can help patients lower costs.

Short-term manufacturing problems are happening as the demand for Adderall and other stimulant medications for ADHD have increased, data from Arrive Health shows.

Landing the number 61 spot, Arrive Health was named Colorado’s 4th fastest-growing tech company this year.

Arrive Health data illustrates the growing demand for amoxicillin, especially in those aged 0-12 years old.

Arrive Health ranks number 61 on Deloitte Technology Fast 500 list of fastest-growing companies in North America.

New Arrive Health data shows a recent spike in psychiatric medication prescriptions in August, as well as medications for anxiety, depression, and other mental health conditions.

These StartUp Health portfolio companies represent the diverse, impactful, and innovative work being done by our global army of Health Transformers throughout the world of digital health.

Newly published Arrive Health data shows behavioral health prescriptions surged early in the pandemic, leveled off, and began to rise again more recently.

A new study from the AMA shows physicians growing ever more comfortable with health care technology, including in the non-clinical area of price transparency and related data tools.